1. EULAR randomised controlled trial of pulse cyclophosphamide and methylprednisolone versus continuous cyclophosphamide and prednisolone followed by azathioprine and prednisolone in lupus nephritis. Issue 5 (13th April 2004) Authors: Yee, C-S; Gordon, C; Dostal, C; Petera, P; Dadoniene, J; Griffiths, B; Rozman, B; Isenberg, D A; Sturfelt, G; Nived, O; Turney, J H; Venalis, A; Adu, D; Smolen, J S; Emery, P Journal: Annals of the rheumatic diseases Issue: Volume 63:Issue 5(2004) Page Start: 525 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. The 10-year follow-up data of the Euro-Lupus Nephritis Trial comparing low-dose and high-dose intravenous cyclophosphamide. Issue 01 (20th January 2009) Authors: Houssiau, F A; Vasconcelos, C; D'Cruz, D; Sebastiani, G D; de Ramon Garrido, E; Danieli, M G; Abramovicz, D; Blockmans, D; Cauli, A; Direskeneli, H; Galeazzi, M; Gül, A; Levy, Y; Petera, P; Popovic, R; Petrovic, R; Sinico, R A; Cattaneo, R; Font, J; Depresseux, G Journal: Annals of the rheumatic diseases Issue: Volume 69:Issue 01(2010) Page Start: 61 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗